TirraMind

Pricing

Three infrastructure tiers plus a lightweight weekly digest. Every tier is billed monthly via Paddle; cancel anytime.

Data Platform

$500 / month, up to $5,000 (enterprise)

Unified query layer across public market and regulatory data — the infrastructure for deterministic signal extraction and entity indexing. Coming soon at production scale.

  • Unified interface across SEC EDGAR, CFTC, GDELT, AIS, and other regulated sources
  • Deterministic feature computation (BOCPD, HMM regime detection, spectral analysis) — the core of our anomaly detection
  • Entity indexing and cross-document relationship resolution — same engine that powers Entity Graph
  • Enterprise: custom data sources, batch pipelines, dedicated infra — contact us
Coming soon — enterprise deployment in progress

Entity Graph

$300 / month, up to $2,000 (enterprise)

A deterministic, no-LLM pipeline that extracts entities and relationships from ingested documents — PDF, news, CSV, plain text — with every mention and link tracing back to the exact source sentence it came from. Cross-document co-occurrence — the same pair recurring across sources, not just one — is the signal.

  • Entity search — every mention and relationship cites its source document and sentence; confidence scores are deterministic (co-occurrence-based), not model output
  • Cross-document co-occurrence analytics — surfaces entities and relationships that recur across the ingested corpus
  • Graph export (adjacency list) and degree-centrality / hub analysis
  • Real production entity graph — paginated entities and links from the same store the system's own graph model trains on (ids, canonical names, types, confidence, link type); raw signal/observation values are not exposed
  • Enterprise: custom entity types, private document ingestion, on-prem option
GET /evidence/graph?q=nvidia GET /evidence/analytics?q=nvidia GET /evidence/graph/centrality?top=10 GET /api/v1/entity-graph/entities?type=&limit=100 GET /api/v1/entity-graph/entity?id=<id> GET /api/v1/entity-graph/links?link_type=&min_confidence= Header: X-Brief-Key: <your key>

Scheduler

$50 / month, up to $2,000 (enterprise)

Read-only visibility into the DAG-based execution engine that runs our own pipeline in production — run history, status, and timing per DAG.

  • List recent runs by DAG name, with status and timing
  • Inspect a specific run's node-level results
GET /api/v1/dag/runs?dag_name=daily_collection&limit=20 Header: X-Brief-Key: <your key>

Brief

$19 / month

Weekly positioning and flow anomaly digest built on deterministic z-scores over multi-year baselines and Bayesian online changepoint detection (BOCPD). No LLM, no predictions — just the math. The entry rung of metered API access.

  • Positioning extremes and flow anomalies detected via BOCPD over multi-year CFTC commitment-of-traders baselines (up to ~160 weekly observations), DeFi TVL series of 1,000+ points, and instrument volatility
  • Weekly digest delivered as markdown and JSON — includes entity IDs, flagged timestamps, z-scores, and raw signal values for reproducibility
  • Metered API access: same subscriber key as other tiers; usage tracked in your account
GET /brief GET /brief.json GET /brief.md POST /api/v1/rotate-key GET /api/v1/usage Header: X-Brief-Key: <your key>

Questions

Can I combine tiers? Yes — each tier is billed and gated independently by your subscriber key. Contact us for a bundled rate across two or more tiers.
What does "up to $X enterprise" mean? The listed price is the entry point. Larger universes, custom integrations, dedicated support, or on-prem deployment move you up within that tier's range — priced per engagement.
Is any of this LLM-generated? No. Every tier you're billed for runs on deterministic math (BOCPD, HMM, spectral, graph analytics) or auditable rule-based scoring — nothing here hallucinates a fact, and none of today's tiers depend on our graph model's output. That model is still in training; we'll only sell a prediction tier once it clears an independent, walk-forward backtest against a naive baseline.